George W. Lloyd, EVP, Investments & CLO at Royalty Pharma plc (RPRX), sold 270,622 shares at $39.01 ($10.4M) on 2025-11-19, disclosed to the SEC on 2025-11-21.
Scheduled sale ($10.4M) by EVP, Investments & CLO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.28 | 47,798 | $1.8M | 17.6% |
| 2 | $38.28 | 25,530 | $977K | 9.4% |
| 3 | $38.28 | 25,530 | $977K | 9.4% |
| 4 | $38.28 | 47,401 | $1.8M | 17.5% |
| 5 | $38.28 | 47,401 | $1.8M | 17.5% |
| 6 | $38.28 | 47,798 |
| $1.8M |
| 17.6% |
| 7 | $38.29 | 2,770 | $106K | 1.0% |
| 8 | $38.29 | 2,770 | $106K | 1.0% |
| 9 | $39.01 | 4,628 | $181K | 1.7% |
| 10 | $39.01 | 2,470 | $96K | 0.9% |
| 11 | $39.01 | 2,470 | $96K | 0.9% |
| 12 | $39.01 | 4,599 | $179K | 1.7% |
| 13 | $39.01 | 4,599 | $179K | 1.7% |
| 14 | $39.01 | 4,628 | $181K | 1.7% |
| 15 | $39.03 | 230 | $9K | 0.1% |
| Total | $38.34 avg | 270,622 | $10.4M | 100% |
| Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |
| RPRX | SELL | 2023-02-27 | $1.9M | — | Filing → |